Are You A Member of The NICI?

For the first time ever, CEOs, investors, and some of the most politically connected players in this industry have joined forces to take on the cannabis market together.

Never before has a multi-billion dollar industry emerged so quickly. Never before has the average investor held such an advantage over the large Wall Street banks.

And, more importantly, never before has the path to real, life-altering wealth in the stock market been so obvious, if you know where to invest.

That’s where the National Institute for Cannabis Investors comes in.

As a member, we’ll show you how to fast-track your path to becoming a marijuana millionaire. All you have to do is follow along as our team of analysts deliver insider insight on this economic phenomenon.

More importantly, each week, they’ll lay out an easy to follow blueprint for how to profit from America’s next great industry.

Click here to get the full details. 

summit

Don’t Stop Here

More To Explore

Market Brief: AI Risks and Fed Minutes Incoming

Market Snapshot Market Pulse: U.S. stocks edged sideways, buoyed by fresh AI chatter that kept tech afloat while industrial sectors shrugged off supply-chain jitters. Bond

AARD: 56% Drop Sparks Urgent Investor Scrutiny!

Overview: Aardvark Therapeutics, Inc. (Nasdaq: AARD) is a clinical-stage biotech focused on therapies for metabolic diseases and Prader-Willi Syndrome (PWS) – a rare genetic disorder

Gene-Editing Goldrush Meets AI and ETF Plays

Opening Recap Market Pulse: Gene-editing fervor rippled through biotech circles after a Mordor Intelligence report flagged double-digit growth in cell line development through 2031. Down